Atrial fibrillation diagnosis associated with 45% increased risk of mild cognitive impairment

US Med­ic­aid pro­grams will test a pay­ment mod­el that will re­im­burse mul­ti­mil­lion-dol­lar gene ther­a­pies based on pa­tient out­comes, in an ear­ly step to­ward ef­forts to

The House En­er­gy & Com­merce Com­mit­tee ad­vanced its pan­dem­ic pre­pared­ness reau­tho­riza­tion leg­is­la­tion Wednes­day, de­spite firm op­po­si­tion from the pan­el’s De­moc­rats who al­so rein­tro­duced their own